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Abstract 
Background: Bloodstream infections (BSI) are life‑threatening emergencies. Identification of the common pathogens 
and their susceptibility patterns is necessary for timely empirical intervention.
Methods: We conducted a 4‑year retrospective analysis of blood cultures from all patients excluding neonates at the 
Korle‑Bu Teaching hospital, Ghana, from January 2010 through December 2013. Laboratory report data were used to 
determine BSI, blood culture contamination, pathogen profile, and antimicrobial resistance patterns.
Results: Overall, 3633 (23.16 %) out of 15,683 blood cultures were positive for various organisms. Pathogen‑positive 
cultures accounted for 1451 (9.3 %, 95 % CI 8.5–9.8 %). Infants recorded the highest true blood culture positivity 
(20.9 %, n = 226/1083), followed by the elderly (13.3 %, n = 80/601), children (8.9 %, n = 708/8000) and adults (7.2 %, 
n = 437/6000) (p = 0.001 for Marascuilo’s post hoc). Overall occurrence of BSI declined with increasing age‑group 
(p = 0.001) but the type of isolates did not vary with age except for Citrobacter, Escherichia coli, Klebsiella, Salmonella, 
and Enterococcus species. Gram negative bacteria predominated in our study (59.8 %, n = 867/1451), but the com‑
monest bacterial isolate was Staphylococcus aureus (21.9 %, n = 318/1451)—and this trend run through the various 
age‑groups. From 2010 to 2013, we observed a significant trend of yearly increase in the frequency of BSI caused by 
cephalosporin‑resistant enterobacteria (Chi square for trend, p = 0.001). Meropenem maintained high susceptibility 
among all Gram‑negative organisms ranging from 96 to 100 %. Among Staphylococcus aureus, susceptibility to cloxa‑
cillin was 76.6 %.
Conclusion: Our study shows a significantly high blood culture positivity in infants as compared to children, adults 
and the elderly. There was a preponderance of S. aureus and Gram‑negative bacteria across all age‑groups. Merope‑
nem was the most active antibiotic for Gram‑negative bacteria. Cloxacillin remains a very useful anti‑staphylococcal 
agent.
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Background
Developing countries, especially in Africa, have a dis-
proportionate burden of global bacterial bloodstream 
infections (BSI). This contributes significantly to 
morbidity, mortality, and increased health care costs 
[1–3]. The potential outcomes of bloodstream infec-
tions are such that treatment is often empirical, due to 
delays in performing and receiving blood culture results. 
In developing countries, this is further worsened by the 
unavailability of well-resourced microbiology facilities 
[4]. Empirical antibiotics used in such instances are usu-
ally based on international guidelines and not guided by 
local susceptibility data [5]. The rise in antibiotic resist-
ance worldwide means that the likelihood of inadequate 
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therapy in BSI is heightened, with increased chances of 
poor therapeutic outcomes [6, 7]. Knowledge of the local 
antibiotic resistance profile of bacteria increases the 
probability of selecting effective empirical therapy [2, 8]. 
In a recent study on the cost-effectiveness of bloodstream 
infection surveillance for the management of sepsis in 
low-resource settings, Penno et al. [5] showed that anti-
biotic prescribing, based on local antibiogram is able to 
save 534 additional lives per 100,000 patients. The finding 
suggests that it is crucial to monitor emerging trends in 
resistance at the local level to support clinical manage-
ment. However, data on antimicrobial resistance, espe-
cially regarding trends in BSI, remain scarce in Ghanaian 
healthcare settings including Korle-Bu Teaching Hospital 
(KBTH).
Published data describing BSI in KBTH are limited to 
short study periods [9] and have mainly focused on chil-
dren [10]. Using a large collection of blood culture data, 
we have examined trends in pediatric and adult BSI over 
4  years at KBTH; determined blood culture yields and 
contamination rate; and analyzed the antibiotic suscepti-
bility profiles of the associated organisms, with empha-




This was a hospital based retrospective analysis of blood 
culture reports from January 2010 to December 2013 at 
the Korle-Bu Teaching Hospital in Ghana, West Africa. 
We followed guidelines for the reporting of studies con-
ducted using observational routinely-collected health 
data (RECORD) [11]. The KBTH is a 2000-bed tertiary 
teaching hospital with about 200 admissions per day [12]. 
The central outpatient department records about 29,757 
patients per month [12]. The hospital covers all medical 
specialties and provides referral healthcare services to an 
estimated population of 24 million Ghanaians.
Study settings and population
We collated blood culture results of patients older than 
28 days, from the bacteriology unit of the Microbiology 
Laboratory in KBTH. Data on BSI of patients ≤28 days 
old will be published elsewhere. The bacteriology unit 
of KBTH processes over 40,000 clinical cultures annu-
ally. To obtain a good representation of the repertoire of 
BSI isolates occurring at a tertiary health facility, we have 
included all blood culture results of patients primarily 
receiving healthcare at the KBTH (n = 15,072) or second-
arily referred to the laboratory from other health facilities 
for microbiological investigations (n = 611). We included 
data for the period January 2010 to December 2013. Data 
prior to this period were not properly archived and there-
fore difficult to access.
Selection, review and extraction of data from laboratory 
reports
A data entry team comprising three bacteriologists and 
a physician who assisted with the medical reconciliation 
of data conducted a manual work-through of laboratory 
paper records to select blood cultures conducted between 
2010 and 2013. Selected blood culture reports were 
reviewed and extracted into a computerized database (Sta-
tistical Package for Social Sciences, Version 20.0) as the 
primary data source. We had no independent means of val-
idating laboratory results, thus reports were excluded from 
entry on the basis of incomplete data if results regarding 
the positivity or otherwise of blood cultures were incon-
clusive. The quality of abstracted data was assessed by an 
independent reviewer in a standardized manner by com-
paring paper records to the electronic entries. Disagree-
ments between data were resolved by consensus between 
the reviewer and the data entry team. Extracted informa-
tion included patient demographics, bacterial and fungal 
isolates, BSI categorization, and antibiogram of isolates. 
Reports for patients aged ≤28  days were not considered 
for analysis. True positive cultures were those with iden-
tified bacteria plus corresponding susceptibility results, or 
yeast. Organisms, including Micrococcus species, Bacillus 
species, and diphtheroids were classified as contaminants. 
For the majority of patients, only a single blood culture 
was submitted per infection episode. Where duplicate cul-
tures were submitted, and the same organism was isolated 
within 14 days of the previous culture, then the latter iso-
late was excluded except when there was variation in anti-
biotic susceptibility pattern.
Data source/methods of laboratory assessment for blood 
cultures
For patients with suspected sepsis, local guidelines rec-
ommended the inoculation of 1–3  mL (for paediatric 
patients; however, for older children, larger blood inoc-
ulums of 10  mL were encouraged) and 8–10  mL (for 
adults) directly into Bactec® culture vials (Becton–Dick-
inson, USA). Routinely at the laboratory, cultures were 
processed with the BACTEC 9240 blood culture system 
(Becton–Dickinson, NJ, USA) according to manufactur-
er’s instructions. Where bacterial growth was detected in 
vials, Gram-stains were performed; and subcultures were 
typically made onto appropriate media based on Gram-
stain results. Bacterial isolates were identified using rou-
tine biochemical methods. Bacteria speciation was done 
with the BBL® Crystal identification system (Becton–
Dickinson, NJ, USA). For positive fungal blood cultures, 
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organisms were identified on the basis of morphology. 
As part of regular practice at the laboratory, consultant 
microbiologists evaluated all positive blood cultures to 
categorize isolates as contaminants or true pathogens. 
Susceptibility testing for bacterial pathogens were con-
ducted using the Kirby-Bauer disc diffusion method with 
antibiotic discs; and these tests were interpreted accord-
ing to guidelines by the Clinical and Laboratory Stand-
ards Institute (CLSI) [13].
Antibiotic resistance phenotypes
We assessed the occurrence of six epidemiologically 
important bacterial pathogens: vancomycin resistant 
Enterococcus species (VRE) [based on in  vitro suscepti-
bility to vancomycin disk (30  μg)], methicillin resistant 
Staphylococcus aureus (MRSA) [based on in  vitro sus-
ceptibility to cefoxitin disk (30  μg)], penicillin resistant 
streptococci (PRS) [based on in  vitro susceptibility to 
ampicillin disk (10  μg)], cephalosporin resistant entero-
bacteria (Ceph-R Ent) [based on in  vitro susceptibility 
to cefotaxime disk (30  μg)], multi-drug resistant Pseu-
domonas species (MDR Ps.) and multi-drug resistant 
Acinetobacter species (MDR Act). A multidrug resistant 
(MDR) phenotype was defined, relative to the panel of 
antibiotics reported for each bacteria, as in  vitro non-
susceptibility to ≥1 agent in ≥3 antimicrobial classes: 
penicillins, cephalosporins, β-lactamase inhibitor com-
binations, carbapenems, tetracyclines, folate pathway 
inhibitors, glycopeptides, fluoroquinolones, chloram-
phenicol, aminoglycosides, and macrolides [14].
Data analysis
Data analysis was performed with the Statistical Package 
for Social Sciences, Version 20.0. The distribution of BSI 
and resistance profiles of bacterial isolates were assessed 
using descriptive methods. Blood culture positivity and 
contamination levels were calculated by dividing positive 
blood cultures and contaminants respectively by the total 
number of blood cultures submitted. Susceptibility tests 
reports were classified as resistant or susceptible, and the 
data expressed as the proportion of susceptible isolates 
out of the total valid test results for the specific antibiotic 
and pathogen. Missing data were excluded from analysis. 
Study data were compared across four patient age catego-
ries: infants (>28  days–1  year), children (>1–15  years), 
adults (>15–65  years), and the elderly (>65  years). The 
Chi square analysis with Marascuilo’s post hoc tests for 
multiple comparisons was used to compare categorical 
data within patient groups. A Chi square test for linear 
trend was used to assess changes in categorical variables 
over the study period. Continuous data were compared 
using Students’ t test with analyses of variance (ANOVA) 
for multiple comparisons.
Ethical considerations
During the data extraction process, we de-identified 
blood culture reports to ensure complete obscurity from 
laboratory archives. Arbitrary numbers were assigned 
to all reported isolates. Patients’ clinical data were not 
reviewed for analysis. Owing to the retrospective study 
design, and given the anonymized nature of our data, 
patients’ consent for use of the laboratory records could 
not be obtained. Ethical approval for isolates and labora-
tory data was not required as the study was regarded as 
part of routine surveillance measures for infection con-
trol. Study findings are freely available to the hospital for 
the formulation of guidelines for treatment of BSI.
Results
Figure  1 shows the flow diagram for data collation and 
outcome. Overall, a total of 15,683 blood cultures were 
performed for infants (n =  1082), children (n =  8003), 
adults (n = 5987), and the elderly (n = 601). Males com-
prised 53  % (n  =  8312) of patients. The median age of 
the study population was 31.6  years (range 29  days–
69 years). About 3633 (23.16 %) blood cultures were posi-
tive: 1451 (9.3 %, 95 % CI 8.5–9.8) were considered true 
pathogens and 2182 (13.9  %) considered contaminants. 
The rate of BSI was 92.5 per 1000 blood cultures submit-
ted to the laboratory, with no significant variation across 
the years under review (2010, 82.4 per 1000 blood cul-
tures; 2011, 94.2 per 1000 blood cultures; 2012, 87.2 per 
1000 blood cultures; 2013, 90.3 per 1000 blood cultures: 
p  =  0.0841 for Marascuilo’s post hoc). The median age 
of patients with BSI was 13.5 years (range 29–81 years). 
Chi square for linear trend analysis showed that the over-
all occurrence of BSI declined with increasing age-group 
(p  =  0.001), but most of the isolates did not vary with 
age (Table  1). The highest true blood culture positiv-
ity was observed among infants (20.9 %, n = 226/1083), 
followed by the elderly (13.3  %, n  =  80/601), children 
(8.9 %, n = 708/8000) and adults (7.2 %, n = 437/6000) 
(p = 0.001 for Marascuilo’s post hoc). The proportion of 
blood cultures positive for various pathogens remained 
similar (p = 0.412 for Chi square test) between patients 
receiving care at KBTH (9.3  %, n  =  1407/15,072) and 
those referred to the laboratory from other health facili-
ties (7.6  %, n =  44/611). In the proceeding analysis, we 
have disregarded comparing results between the two 
sources of blood cultures because there were few true 
positive cultures from the latter.
Distribution of isolates
Gram-negative bacteria accounted for 59.8  % 
(n = 867/1451) of BSI pathogens, whilst Gram-positives 
and fungi accounted for 38.8 % (n = 563/1451) and 1.4 % 
(n  =  21/1451) respectively (p  =  0.001 for Marascuilo’s 
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post hoc)—and the trend was similar within each age-
group. Staphylococcus aureus was the most isolated 
organism (21.9 %, n = 318/1451). The majority of Gram-
negative bacteria belonged to the family Enterobacte-
riaceae (73.9 %, n = 640/867), with Salmonella (11.1 %) 
and Citrobacter (10.2  %) species being the second and 
third most isolated pathogens (Table 1). 
Antibiotic susceptibility
Our results show high levels of ampicillin resistance 
among Gram-negative (Table  2) and Gram-positive 
(Table  3) organisms. Susceptibility among the entero-
bacteria ranged from 0 % among Proteus and Klebsiella 
species to 36.1 % in Salmonella species. There was 100 % 
susceptibility among Neisseria meningitides isolates. 
Fig. 1 Flow diagram for data collation and results outcome. Overall, 24,042 laboratory records were reviewed, 15,683 of which belonged to patients 
>28 days and were eligible for inclusion. Of the 15,683 blood cultures submitted, 1451 were positive with various pathogens
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Among Gram-positive organisms, susceptibility ranged 
from 7.7 % in Enterococcus species to 100 % in Streptococ-
cus pyogenes. Among the aminoglycosides, Gram-nega-
tive organisms maintained high susceptibility to amikacin 
than to gentamicin. For Pseudomonas species, suscepti-
bility of 86.9 and 67.2  % were respectively recorded for 
amikacin and gentamicin, whilst for Citrobacter species, 
susceptibility of 84.7 and 33.1 % were noted. In this study, 
moderate to high level susceptibility of Gram-negative 
organisms to quinolones was recorded, exemplified by 
64.9 and 69.6  % susceptibility of Citrobacter species, as 
well as 100 and 97.6 % susceptibility of Salmonella spe-
cies, to ciprofloxacin and levofloxacin respectively. Most 
enterobacteria showed low to moderate (20–43  %) sus-
ceptibility to cefotaxime. High percentage susceptibility 
were however recorded for Salmonella (95.5  %). Mero-
penem retained high susceptibility among all Gram-neg-
ative organisms, ranging from 96 % among Pseudomonas 
Table 1 Distribution of BSI isolates across age groups
Organism (n, %) Infants (A) 
(29 days–1 year)
Children (B)  
(1–15 years)
Adults (C)  
(15–65 years)
Elderly (D)  
(>65 years)




GNB (n = 867, 59.8 %) 123 (54.4) 407 (57.5) 265 (65.4) 52 (65.0) A = B = C = D 0.002
Enterobacteria (n = 640, 44.1 %) 81 (35.8) 312 (44.1) 203 (46.4) 44 (55.0) A < D = B = C 0.001
 Citrobacter sp. (n = 148, 10.2 %) 14 (6.2) 58 (8.1) 65 (13.0) 11 (13.7) A = B = C = D 0.001
 E. coli (n = 118, 8.1 %) 8 (3.5) 27 (3.8) 60 (13.7) 23 (28.7) A = B < C = D* 0.001
 Enterobacter sp. (n = 105, 7.2 %) 14 (6.2) 53 (7.5) 32 (7.3) 6 (7.5) A = B = C = D 0.731
 Klebsiella sp. (n = 63, 4.3 %) 16 (7.1) 30 (4.2) 14 (3.2) 3 (3.8) A = B = C = D 0.037
 Proteus sp. (n = 9, 0.6 %) 2 (0.8) 3 (0.4) 4 (0.9) 0 A = B = C = D 0.668
 Providencia sp. (n = 4, 0.4 %) 1 (0.4) 1 (0.1) 2 (0.5) 0 A = B = C = D 0.738
 P. agglomerans (n = 2, 0.1 %) 0 1 (0.1) 1 (0.2) 0 A = B = C = D 0.992
 Salmonella sp. (169, 11.6 %) 23 (9.7) 127 (17.9) 18 (4.3) 1 (1.3) B > C = A > D* 0.001
 Serratia sp. (n = 1, 0.1 %) 0 0 1 (0.2) 0 A = B = C = D 0.755
 Other coliform (n = −21, 1.4 %) 3 (1.3) 12 (1.7) 6 (1.4) 0 A = C = D < B 0.429
Non‑fermentative bacilli (n = 223, 15.3 %) 42 (18.5) 92 (12.9) 81 (18.5) 8 (10.0) A = B = C = D 0.818
 Acinetobacter sp. (n = 120, 8.3 %) 24 (10.6) 56 (7.9) 36 (8.2) 4 (5.0) A = B = C = D 0.173
 Pseudomonas sp. (n = 101, 7.0 %) 18 (7.9) 35 (4.9) 44 (10.0) 4 (5.0) A = B < C = D* 0.404
 S. paucimobilis (n = 1, 0.1 %) 0 1 (0.1) 0 0 A = B = C = D 0.334
 S. maltophilia (n = 1, 0.1 %) 0 0 1 (0.2) 0 A = B = C = D 0.759
Other gram negatives (n = 4, 0.2 %) 0 3 (0.4) 1 (0.2) 0 A = B = C = D 0.738
 Chromobacter sp. (n = 1, 0.1 %) 0 0 1 (0.2) 0 A = B = C = D 0.759
 N. meningitides (n = 2, 0.2 %) 0 3 (0.4) 0 0 A = B = C = D 0.350
GPB (n = 563, 36.5 %) 102 (45.1) 289 (40.7) 146 (25.9) 26 (32.5) C < A = B = D 0.0001
 Enterococcus sp. (n = 43, 0.3 %) 8 24 (3.4) 10 (22.8) 1 (1.3) A = B = C = D 0.139
 S. aureus (n = 318, 21.9 %) 60 (26.5) 148 (20.9) 99 (22.6) 11 (13.8) A = B = C = D 0.092
 S. epidermidis (n = 67, 4.6 %) 11 (4.8) 42 (5.9) 12 (2.7) 2 (2.6) A = B = C = D 0.047
 S. agalactiae (n = 1, 0.1 %) 1 (0.4) 0 0 1 (1.3) A = B = C = D 0.984
 S. pneumoniae (n = 35, 2.4 %) 6 (2.6) 23 (3.2) 3 (0.6) 3 (3.8) A = B < C = D* 0.159
 S. pyogenes (n = 3, 0.2 %) 0 1 (0.1) 1 (0.2) 1 (1.3) A = B = C = D 0.217
 S. viridans (n = 48, 3.3 %) 10 (4.4) 23 (3.2) 9 (8.9) 6 (7.5) A = B = C = D 0.739
 Other Streptococcus sp. (n = 48, 3.3 %) 7 (3.1) 28 (4.0) 12 (2.7) 1 (1.3) A = B = C = D 0.243
Fungi (n = 21, 1.3 %) 2 (0.8) 12 (1.7) 5 (1.1) 2 (2.6) A = B = C = D 0.596
 Aspergillus sp. (n = 3, 0.2 %) 0 2 (0.2) 0 1 (1.3) A = B = C = D 0.588
 Candida sp. (n = 17, 1.2 %) 2 (0.8) 10 (1.4) 4 (0.9) 1 (1.3) A = B = C = D 0.816
 Cryptococcus sp. (n = 1, 0.1 %) 0 (0) 0 1 (0.2) 0 A = B = C = D 0.759
True blood culture positivity (n = 1451, 9.3 %) 226 (20.9 %) 708 (8.9 %) 437 (7.3 %) 80 (13.3 %) A > D > B > C* <0.001
Sp., species; GNB, gram negative bacteria; GPB, gram positive bacteria; E. coli, Escherichia coli; P. agglomerans, Pantoea agglomerans; S. paucimobilis, Sphingomonas 
paucimobilis; S. maltophilia, Stenotrophomonas maltophilia; N. meningitis, Neisseria meningitis; S. aureus, Staphylococcus aureus; S. epidermidis, Staphylococcus 
epidermidis; S. agalactiae, Streptococcus agalactiae; S. pneumoniae, Streptococcus pneumoniae; S. pyogenes, Streptococcus pyogenes; S. viridans, Streptococcus viridans; 
2 trend, Chi square for linear trend; Post hoc, comparison compares the proportion of bloodstream infections among age‑groups
* Comparisons with significant (p < 0.05) differences
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species to 100  % among Citrobacter species. Among 
Staphylococcus aureus, susceptibility to cloxacillin over 
the period was 76.6 %, cefuroxime 48.5 %, erythromycin 
70 %, co-trimoxazole 24 %, gentamicin 68 % and vanco-
mycin 100 %. Isolates of Streptococcus pneumoniae were 
moderately susceptible to penicillin (32.5 %) and ampicil-
lin (46.7), but highly susceptible to erythromycin (84.2 %) 
and vancomycin (100 %).
Trends in antibiotic susceptibility patterns
In Fig.  2, we assessed antibiotic susceptibility patterns 
over 4 years, looking out for significant trends. There was 
a significant rise in susceptibility to penicillin (p = 0.001), 
ampicillin (p  =  0.000), cefuroxime (0.0000), cloxacil-
lin (p =  0.0000), cotrimoxazole (p =  0.012), cefotaxime 
(p = 0.0197) and chloramphenicol (p = 0.001). Figure 3 
shows the occurrence of some epidemiologically impor-
tant antibiotic resistance phenotypes: VRE, MRSA, PRS, 
Cef-R Ent, MDR Ps, MDR Act, and all MDRs. From 2010 
to 2013, we observed a significant trend towards increas-
ing frequency of BSI caused by Cef-R Ent (Chi square for 
trend, p  =  0.001). No other resistant phenotype varied 
with years.
Discussion
Bloodstream infections accounted for 9.3  % of blood 
cultures and varied significantly within age-groups, 
where the highest prevalence was recorded among 
patients at the extremes of ages: the elderly (13.3  %) 
and infants (20.9  %). The reasons for this distribu-
tion is unclear, as risk factors for developing BSI were 
not assessed in this study. Nevertheless, infants were 
significantly more likely to have BSI compared with 
patients aged >3  years. There may be several reasons 
for this association. Infants are likely to have frequent 
exposure to healthcare environments or participate in 
activities that predispose them to microbial contamina-
tion. They also have poor skin integrity and an imma-
ture immune system [15–19].
In keeping with previous studies from Ghana [20, 21], 
Gram-negative bacteria predominated in our study, but 
the majority of bacterial findings were S. aureus, which 
also predominated in other studies from Guinea-Bissau 
[22], Nigeria [16] and Malawi [23]. We believe that the 
aetiology of BSI is changing, so that BSI are due largely to 
Gram-negative bacteria, but with a significant contribu-
tion from Gram-positive isolates, mostly Staphylococcus 
species. Other studies in Africa have documented this 
phenomenon, attributing the predominance of Gram-
positive bacteria (mostly S. pneumoniae and S. aureus) 
to community-acquired infections [24–26] and Gram-
negative bacteria (predominantly E. coli and K. pneu-
moniae) to healthcare related infections [27]. We are 
unable to determine which BSI were healthcare related 
or community-acquired because of insufficient data on 
inpatient and outpatient status. The presence of Strep-
tococcus pneumoniae as a cause of BSI was uncommon 
in our study. This could partially be attributable to pneu-
mococcal vaccine introduced in January 2012. Immu-
nization of infants with the vaccine has led not only to 
major declines in childhood invasive pneumococcal sep-
sis but also to a reduction in infections among adults due 
to herd immunity [27]. It is the experience in KBTH that 
Salmonella species constitute a prominent pathogen in 
Table 3 Percentage susceptibility of gram positive pathogens
Data not available for blank cells
Pen penicillin, Amp ampicillin, Am/cl amoxicillin clavulanic acid, Gen gentamicin, Cef cefuroxime, Cot cotrimoxazole, Tet tetracycline, Chl chloramphenicol, Ctx 
cefotaxime, Chl chloramphenicol
Organisms Pen Amp Amc/cl Gen Cef Ox Vanc Ery Tet Ctx Cot Chl
Staphylococcus 
epidermidis























Enterococcus sp. 1/38 
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(100)
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BSI, with a preponderance of non-typhoidal salmonel-
lae over typhoidal salmonellae. Children under 5  years 
bear the brunt of the disease [28]. These observations 
are generally consistent with findings from other African 
studies, particularly in malaria-endemic regions, where 
Salmonella species have predominated in BSI [29, 30].
Favoured by of their low toxicity, broad spectrum and 
comparatively high effectiveness, the cephalosporin 
Fig. 2 Trends in antibiotic susceptibility patterns over 4 years (2010 through to 2013). p values calculated for Mantel–Haenszel Chi square for linear 
trends
Fig. 3 Antimicrobial resistance phenotypes over 4 years (2010 through to 2013). p values calculated for Mantel–Haenszel Chi square for linear 
trends. MDRs multidrug resistant bacteria, VRE vancomycin resistant Enterococci, MRSA methicillin resistant Staphylococcus aureus, PRS penicillin 
resistant Streptococci, Cef-R Ent cephalosporin resistant Enterobacteriaceae, MDR Ps multidrug resistant Pseudomonas aeruginosa, MDR Act multidrug 
resistant Acinetobacter species
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antibiotics are widely used in Ghana. A worrying obser-
vation is the increasing isolation of cephalosporin resist-
ant Enterobacteriaceae over the 4-year review period. The 
enterobacteria constituted over 40 % of the bloodstream 
pathogens. Given that the variety of class C cephalospori-
nases (AmpCs) and extended spectrum β-lactamases 
(ESBLs) remain the principal mechanisms for cephalo-
sporin resistance worldwide [31–33], the high levels of 
cephalosporin resistance observed in our study may be 
compatible with results from other studies in Ghana, 
demonstrating high levels of ESBLs (>45  %) among the 
enterobacteria [31, 34].
Based on the low frequency of fungi and the domi-
nance of both GPB and GNB, it may be necessary for 
clinicians to consider suitable empiric regimens that 
provide adequate cover for both bacterial groups. Cefo-
taxime, gentamicin, ciprofloxacin and amoxicillin plus 
clavulanic acid, in various combinations, have been the 
predominant empiric therapies for bloodstream infec-
tions in Ghana [35]. We have demonstrated here and 
in previous studies that the general antibiogram of the 
GNB and GPB reveal an overall high resistance to these 
routinely used drugs [31, 32]. Our observations are in 
consonance with other studies in Ghana and at Korle-
Bu teaching Hospital, which found high resistance to 
ampicillin, gentamicin and cefotaxime among bacteria 
isolates of various infections [31, 32, 36]. Carbapenem 
was the most active antibiotic against Gram-negative 
infections. Meanwhile, cloxacillin remained a very use-
ful anti-staphylococcal agent due the relatively low 
prevalence of MRSA.
This study has several limitations. Being retrospective, 
we were unable to ascertain the standardization of tech-
niques for blood cultures and laboratory procedures for 
individual patients. The study is also unable to evaluate 
the accuracy of bacteria isolates classified as contami-
nants in laboratory records. As the study lacks compre-
hensive clinical data or information on recent antibiotic 
use and/or hospitalization, our data on the occurrence of 
BSI should be interpreted with caution. Finally, our study 
was performed in a single center, and cannot be general-
ized to the entire patient population in Ghana. Our study 
nonetheless provides relevant data which may be used to 
guide empirical therapy, change antibiotic prescription 
policy in our institution or serve as a baseline for future 
research. We recommend future studies to ascertain the 
changing eligibility of our findings over time beyond the 
review years reported in this study.
Conclusion
Our study shows that blood culture positivity was sig-
nificantly higher in infants compared to children, adults 
and the elderly; with a preponderance of S. aureus and 
Gram-negative bacteria in all age-groups. The findings 
presented here suggest the need to review empiric antibi-
otic options in these patient populations, given the rela-
tively low susceptibility of the bacterial isolates to many 
routinely used antibiotics.
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